Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...
Online sellers of knockoff GLP-1 drugs have seized on shortages as an opportunity to advertise a more steady, lower-cost supply of the products compared to branded versions. One such company, Hims & ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
What will the new Guidance mean for pharma companies ... To reduce such errors, the FDA seemingly takes a "pro-trade dress" stance by warning against "look-alike" containers and stressing the ...
The report warns that big pharma companies can't rest on their laurels ... as by the time products gain FDA approval, 56 per cent have been acquired or in-licensed by one of the big players.
Hims and Hers is airing an ad about its copycat GLP-1 drugs during Sunday’s Super Bowl. Critics say it violates FDA rules.
Business owners have 15 days to respond to FDA warning letters. Warning letters often are not issued until a company has been given months to years to correct problems. The FDA has issued warning ...
The biotech company ... this recent FDA approval, Vertex stock makes a no-brainer biotech stock to buy and hold for the long term. Adria Cimino has positions in Vertex Pharmaceuticals.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company Vertex Pharmaceuticals ... director of the FDA's Center for Drug ...
Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830, now branded as Onapgo, finally earned the ...
The Trump administration’s overarching message to the legions of people powering the federal government is simple: Leave.
If you still have Marketside Broccoli Florets from Walmart, the FDA says to throw them ... Braga Fresh, a Soledad, California-based company, issued a product warning for the broccoli product ...